Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international expertsRory M. Shallis, Amer M. Zeidan, Naval Daver et al.|The Lancet Haematology|2023Cited by 18
Venetoclax-Based Therapy Versus Intensive Chemotherapy Followed By Allogeneic-Stem Cell Transplantation for High-Risk Elderly Acute Myeloid LeukemiaAlexandre Iat, Sylvain Garciaz, Daniel J. DeAngelo et al.|Blood|2024Cited by 2
Comparative Analysis of Outcomes with HMA Plus Venetoclax Vs Intensive Chemotherapy in AML Patients Harboring Very-High Risk CytogeneticsLuis E. Aguirre, Maximilian Stahl, Jan Philipp Bewersdorf et al.|Blood|2024Cited by 1
The Prognostic and Predictive Value of <i>RUNX1</i> Mutations in Newly Diagnosed Acute Myeloid Leukemia - an International Multicenter Cohort StudyRebecca P. Bystrom, Maximilian Stahl, Jan Philipp Bewersdorf et al.|Blood|2024Cited by 0